Scientific Programme

The Scientific Programme will run from Monday 5 October to Thursday 8 October. The Programme is currently under development and will be finalised at the end of August. The full Programme will be shared early September. There will be no competing sessions during the Congress. Each day will start at 11.00am UK time, the Programme Overview below reflects the outline agenda. The Congress welcomes abstract submissions, and whilst only a small number can be accepted for oral presentation, we plan a sizeable ePoster area within the Congress site, with the ability to add slides with audio commentary.

Confirmed Keynote Lectures

Monday 5 October –11:00-12:00 BST
COVID-19: Where are We Now and What Next? – Karine Lacombe, Paris, France

Tuesday 6 October – 11:00-12:00 BST
HIV and ObesityAndrew Carr, Melbourne, Australia

Wednesday 7 October 11:00-12:00 BST
PrEP in PracticeJean-Michel Molina, Paris, France

Lock Lecture

HIV Glasgow is honoured to have been chosen by the Royal College of Physicians and Surgeons of Glasgow to present the Lock Lecture as part of the Scientific Programme. The Lock Lecture is given the name in memory of the Lock Hospital in Glasgow.

Monday 5 October –16:00-16:45 BST
Managing costs while delivering state-of-the-art HIV care –  Rochelle Walenksy, Boston, MA, USA

Confirmed Speakers

Marta Boffito, London, UK
Pedro Cahn, Buenos Aires, Argentina
Steven Deeks, San Francisco, CA, USA
Huldrych Günthard, Zürich, Switzerland
Sabine Hermans, Amsterdam, The Netherlands
Daniel Kuritzkes, Boston, MA, USA
Hermione Lyall, London, UK
Mala Maini, London, UK
Santiago Moreno, Madrid, Spain
Cristina Mussini, Modena, Italy
Eugenia Negredo, Barcelona, Spain
Chloe Orkin, London, UK
Jean Philippe Spano, Paris, France

Preliminary Topics

  • Cancer screening and treatment
  • Challenging cases in HIV
  • COVID Country Focus Roundtable
  • Do we need to worry about ART drug resistance anymore?
  • HBV cure
  • HIV and ageing
  • HIV and TB
  • HIV cure
  • Long-acting injectables for ART
  • Novel ART compounds
  • Two-drug regimens
  • Vaccines update
  • What’s new in HIV paediatrics?
  • Women in clinical trials

As in previous years, the programme will be of interest to clinical investigators from across the globe to review current research and discuss its implications for HIV management strategies. Although there have been significant advances in treatment, new challenges have now appeared. This Congress has moved into areas beyond treatment to look at prevention and cure. The role of people living with HIV in treatment decisions and self-management will feature and we look forward to perspectives in the programme from the community.

If HIV Glasgow is new to you, you can get a flavour of the Congress by visiting the webcasts from 2018. Details of abstracts and posters from previous meetings are also available via this site.